Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

NTR 2.0: a rationally engineered prodrug-converting enzyme with substantially enhanced efficacy for targeted cell ablation.
Sharrock AV, Mulligan TS, Hall KR, Williams EM, White DT, Zhang L, Emmerich K, Matthews F, Nimmagadda S, Washington S, Le KD, Meir-Levi D, Cox OL, Saxena MT, Calof AL, Lopez-Burks ME, Lander AD, Ding D, Ji H, Ackerley DF, Mumm JS
Nat Methods. 2022 Feb;19(2):205-215. doi: 10.1038/s41592-021-01364-4. Epub 2022 Feb 7.
PubMed Article

Plasmids from Article

ID Plasmid Purpose  
1586515xUAS:GAP-tagYFP-P2A-NfsB_Vv F70A/F108Y,he:tagBFP2making transgenics expressing a UAS driven YFP and NTR 2.0
Loading...
1586525xUAS:GAP-EGFP-P2A-NfsB_Vv F70A/F108Y,he:tagBFP2making transgenics expressing a UAS driven eGFP and NTR 2.0
Loading...
1586535xUAS:GAP-mCherry-P2A-NfsB_Vv F70A/F108Y,he:tagBFP2making transgenics expressing a UAS driven mCherry and NTR 2.0
Loading...
1586545xQUAS:GAP-tagYFP-P2A-NfsB_Vv F70A/F108Y,he:ECFPmaking transgenics expressing a QUAS driven YFP and NTR 2.0
Loading...

Antibodies from Article